Research ArticleArticle
Effect of Bosentan on Systemic Sclerosis-associated Interstitial Lung Disease Ineligible for Cyclophosphamide Therapy: A Prospective Open-label Study
YOSHIAKI FURUYA and MASATAKA KUWANA
The Journal of Rheumatology October 2011, 38 (10) 2186-2192; DOI: https://doi.org/10.3899/jrheum.110499
YOSHIAKI FURUYA
MASATAKA KUWANA
REFERENCES
- 1.↵
- 2.↵
- Steen VD,
- Medsger TA
- 3.↵
- 4.↵
- 5.↵
- Nannini C,
- West CP,
- Erwin PJ,
- Matteson EL
- 6.↵
- 7.↵
- Khanna D,
- Furst DE,
- Clements PJ,
- Tashkin DP,
- Eckman MH
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Denton CP,
- Pope JE,
- Peter HH,
- Gabrielli A,
- Boonstra A,
- van den Hoogen FH,
- et al.
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- Koopman WJ
- Medsger TA Jr.
- 20.↵
- Galiè N,
- Hoeper MM,
- Humbert M,
- Torbicki A,
- Vachiery JL,
- Barbera JA,
- et al.
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- Kuwana M,
- Sato S,
- Kikuchi K,
- Kawaguchi Y,
- Fujisaku A,
- Misaki Y,
- et al.
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- Furst DE,
- Khanna D,
- Clements PJ,
- Sullivan K,
- Tashkin DP
- 31.↵
- 32.↵
- 33.↵
- Matucci-Cerinic M,
- Denton CP,
- Furst DE,
- Mayes MD,
- Hsu VM,
- Carpentier P,
- et al.
- 34.↵
- Kuhn A,
- Haust M,
- Ruland V,
- Weber R,
- Verde P,
- Felder G,
- et al.
- 35.↵
- Giordano N,
- Puccetti L,
- Papakostas P,
- Di Pietra N,
- Bruni F,
- Pasqui AL,
- et al.
In this issue
The Journal of Rheumatology
Vol. 38, Issue 10
1 Oct 2011
Effect of Bosentan on Systemic Sclerosis-associated Interstitial Lung Disease Ineligible for Cyclophosphamide Therapy: A Prospective Open-label Study
YOSHIAKI FURUYA, MASATAKA KUWANA
The Journal of Rheumatology Oct 2011, 38 (10) 2186-2192; DOI: 10.3899/jrheum.110499